Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster viewing 06

YO30 - Demographic, Clinical Profile and Outcomes of Cancer Patients with Covid-19 Infection In a Tertiary Hospital Davao City: A Case Series


03 Dec 2022


Poster viewing 06


COVID-19 and Cancer

Tumour Site


Perlita Joanne Yu


P.J.D. Yu1, K.J.N. Demegillo2

Author affiliations

  • 1 Internal Medicine Department, Southern Philippines Medical Center, 8000 - Davao City/PH
  • 2 Internal Medicine Dept., Davao Doctors Medical Tower, 8000 - Davao City/PH


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract YO30

Case summary


Patients with cancer are at a higher risk for COVID-19 infection with consequently worse outcomes. This case series aim is to understand the demographic, clinical profile and outcomes of cancer patients with COVID-19 in a tertiary hospital in Davao City to provide for better quality of care for this subset of patients.


Cancer patients with COVID-19 infection admitted at a tertiary hospital in Davao City were identified. Data were obtained through chart review. Information included were from patients diagnosed from March 2020 to September 22, 2020.


Fourteen cancer patients were diagnosed with COVID-19, with a median age of 45 years (range 19-61 years), and 10 (71%) are females. Three (21%) patients have hypertension and diabetes. Tumors mostly were from the CNS (21%) while breast, GUT, head and neck, lymphoma each represent 14% of the total cases. 64% of patients have stage 4 disease, 3(21%) patients had stage 3. Four (29%) patients had chemotherapy within the last 3 months of admission. Dyspnea (36%), cough (29%) and fatigue (21%) are the most common symptoms. Chest radiograph finding of bilateral infiltrates was seen in 7 (50%) patients. CRP and serum ferritin were the most common laboratory abnormalities seen in 11 (79%) patients. Nine (64%) patients received supplemental oxygen and 4 (29%) needed ventilator assistance. Steroids was given in 3 (21%) patients and 11(79%) received antibiotics. Complications of acute respiratory failure was seen in 5(36%) patients and 2 (14%) had septic shock. There were 6 (43%) COVID-19 related deaths and 7 (50%) patients were discharged. The median length of hospital stay is at 13 days.


Cancer patients have increased risk of contracting COVID-19 infection and are more likely to have worse COVID-19 disease and outcomes.

Clinical trial identification

Editorial acknowledgement

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.